Skip Navigation
Menu
Editorials |17 April 2007

Hungering for HAART

Julio S.G. Montaner, MD; Robert S. Hogg, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia, and Simon Fraser University, Vancouver, British Columbia, Canada.

    Potential Financial Conflicts of Interest: Consultancies: J.S.G. Montaner (Abbott, Argos Theraputics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck-Frosst, Pfizer Inc., Schering, TheraTechnologies, Tibotec, Trimeris), R.S. Hogg (Canadian Institutes of Health Research, National Institutes of Health, Abbott, Boehringer Ingelheim, GlaxoSmithKline), R.S. Hogg (Abbott, Boehringer Ingelheim, GlaxoSmithKline); Honoraria: J.S.G. Montaner (Abbott, Argos Theraputics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck-Frosst, Pfizer Inc., Schering, Thera Technologies, Tibotec, Trimeris), R.S. Hogg (Canadian Institutes of Health Research, National Institutes of Health, Abbott, Boehringer Ingelheim, GlaxoSmithKline), R.S. Hogg (Abbott, Boehringer Ingelheim, GlaxoSmithKline); Grants received: J.S.G. Montaner (Abbott, Argos Theraputics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck-Frosst, Pfizer Inc., Schering, TheraTechnologies, Tibotec, Trimeris), R.S. Hogg (Canadian Institutes of Health Research, National Institutes of Health, Abbott, Boehringer Ingelheim, GlaxoSmithKline).

    Requests for Single Reprints: Julio S.G. Montaner, MD, University of British Columbia, 1081 Burrard Street, Room 667, Vancouver, British Columbia V6Z 1Y6, Canada; e-mail, jmontaner@cfenet.ubc.ca.

    Current Author Addresses: Dr. Montaner: University of British Columbia, 1081 Burrard Street, Room 667, Vancouver, British Columbia V6Z 1Y6, Canada.

    Dr. Hogg: Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada.

×
FULL TEXT
Of any country in the world, South Africa is experiencing one of the most severe HIV epidemics. According to Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates, by the end of 2005, South Africa had 5.5 million people living with HIV and approximately 1000 AIDS-related deaths per day (2). A recent survey found that people in South Africa spend more time at funerals than while shopping, having their hair cut, or having barbecues (3). Clearly, urgent action is needed to reduce the impact of the pandemic in South Africa.
In this context, although the international community has widely commended South Africa's implementation of a government-funded antiretroviral program, the slow pace of implementing this program is causing growing concern. In 2003, South Africa stated an official plan to have more than 380 000 people enrolled in government-funded highly active antiretroviral therapy (HAART) programs between 2005 and 2006 (4). However, by September 2005, only 85 000 people in these programs were receiving treatment (4). According to UNAIDS estimates, at least 79% of South Africans in medical need of HAART had no access to these life-saving treatments as of December 2005 (5). If South Africa is to have an impact on its HIV epidemic, it must address this gap quickly and decisively. Doing so will reduce the HIV mortality rate and the rate of new infections (6), as has been shown elsewhere (7).
FULL TEXT
PDF
Not Available
Citations
Citation

Montaner JS, Hogg RS. Hungering for HAART. Ann Intern Med. 2007;146:609–610. doi: 10.7326/0003-4819-146-8-200704170-00013

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2007;146(8):609-610.

DOI: 10.7326/0003-4819-146-8-200704170-00013

©
2007 American College of Physicians
3 Citations

Related Articles
Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study
Annals of Internal Medicine; 163 (9): 673-680
Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral Therapy–Naive Women With HIV: A Cohort Study
Annals of Internal Medicine; 162 (2): 90-99
Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients: A Cohort Study
Annals of Internal Medicine; 160 (6): 369-379
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
Annals of Internal Medicine; 156 (11): 817-833
View MoreView Less

Related Topics
HIV
Infectious Disease

HIV, Infectious Disease.

PubMed Articles
Perioperative IV Lidocaine Infusion Adverse Reaction: A Case Report.
A A Pract 2019.
The pattern of non-AIDS-defining cancers in the HIV population: epidemiology, risk factors and prognosis. A review.
Curr HIV Res 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×